To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- CEITEC Cluster - bioinformatics - Brünn, République tchèque
- Novartis gains FDA approval for Afinitor as first new treatment in nearly three decades for patients with advanced pancreatic NET
- Breeding of potatoes producing novel starches with improved properties
- Low doses of parabene may increase breast cancer risk
- Novartis drug Afinitor extends progression-free survival in patients with advanced pancreatic NET, study published in NEJM shows - No tumor growth after 18 months in 34% of the patients treated with everolimus versus in 9% of those treated with placebo
